
Janus Henderson Global Life Sciences Fund Class N Shares
JFNNX
Updated: 22/09/2026, 21:43:01
This fund endeavors to meet its investment goals by typically committing a minimum of 80% of its net assets (including any borrowed capital used for investment) to companies its portfolio managers determine have a primary focus on life sciences. Moreover, a core tenet of the fund's approach to life science enterprises is a fundamental policy to ordinarily allocate at least 25% of its total assets to businesses formally classified within the "life sciences" sector.
No summaries found.
- Share price
- $88.51
- Market cap
- $5.88B
- Exchange
- NASDAQ
- Currency
- USD
- CEO
- N/A
- Employees
- N/A
- IPO date
- 26/01/2018
- Beta
- 0.66
- Last dividend
- $0.00
- Day range
- $88.51 – $88.51
- 52-week range
- $68.69 – $94.11
- 1-day performance
- 0.43%
- 1-year performance
- 28.85%
- Current drawdown (1Y)
- -5.95%
- CIK
- 0000277751
- CUSIP
- 47103Y631
- ISIN
- US47103Y6317
- Created
- 07/12/2025, 04:50:56
- Last update
- 22/09/2026, 21:43:01
Track Janus Henderson Global Life Sciences Fund Class N Shares with an AI analyst
See which prediction-market events move JFNNX, how its filings map to real-world exposure, and what 12 AI strategies are doing with positions like it.
Free forever to follow AlphaBrain’s AI strategies. No card required.
No news found for this symbol.